A Case Study of a High-Grade Serous Carcinoma of the Fallopian Tube Transformed into Carcinosarcoma at the Site of Peritoneal Dissemination With Immunohistological Evidence of an Epithelial-Mesenchymal Transition

被引:0
|
作者
Taninaka, Naoko [1 ,2 ]
Ishida, Kazuyuki [1 ]
Takada-Owada, Atsuko [1 ]
Noda, Shuhei [1 ]
Onozaki, Masato [1 ]
Matsuda, Hadzki [1 ]
Kaneko, Yuko [1 ]
Mitsuhashi, Akira [3 ]
Toyoda, Akihiko [4 ]
机构
[1] Dokkyo Med Univ, Dept Diagnost Pathol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan
[2] Dokkyo Med Univ, Sch Med, Mibu, Tochigi, Japan
[3] Dokkyo Med Univ, Dept Obstet & Gynecol, Mibu, Tochigi, Japan
[4] Kamitsuga Gen Hosp, Dept Diagnost Pathol, Kanuma, Japan
关键词
high-grade serous carcinoma; carcinosarcoma; fallopian tube; peritoneal dissemination; epithelial-mesenchymal transition;
D O I
10.1177/10668969241271963
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report a patient in whom a primary high-grade serous carcinoma (HGSC) of the fallopian tube transformed into a carcinosarcoma at the site of peritoneal dissemination, and immunohistological analysis suggested the involvement of an epithelial-mesenchymal transition (EMT). The patient, a 70-year-old woman, had an abdominal mass palpated on admission, and a laparotomy was performed after a close examination. The resected right fallopian tube was cystically dilated, and a solid mass was observed in its lumen. The histological diagnosis was HGSC of the right fallopian tube with a papillary or complex tubular structure composed of tumor cells with marked nuclear irregularities. p53 was overexpressed, and no mesenchymal tumor component was observed. The resected left-sided abdominal mass of the omentum was a solid with a long diameter of 100 mm. Microscopically, the tumor exhibited a mixture of HGSC and high-grade sarcoma with nonspecific differentiation. Furthermore, a heterologous chondrosarcoma was subsequently observed from the high-grade sarcoma. The HGSC component was E-cadherin positive. The high-grade sarcoma component was positive for EMT-related proteins such as zinc finger E-box-binding homeobox 1 (ZEB1) and twist family bHLH transcription factor 1 (TWIST1). The chondrosarcoma component was ZEB1 positive and TWIST1 negative. p53 overexpression was found in all 3 components. The tumor of the omentum suggested that an EMT phenomenon was involved in the tumorigenesis. In this scenario, the primary HGSC of the fallopian tube with obvious invasion demonstrated that the conversion from carcinoma to sarcoma by EMT occurs only with peritoneal dissemination.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] An Unusual Presentation: High-Grade Serous Carcinoma of the Fallopian Tube Manifesting With Altered Mental Status Secondary to a Single Brain Metastasis-A Case Report and Review of the Literature
    Shah, Amar S.
    Menias, Christine O.
    Schmitt, Alessandra
    Chen, Longwen
    Magtibay, Paul M.
    Nguyen, Ba
    Martinez, Felipe
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2024, 31 (02) : 155 - 160
  • [42] VELIA/GOG-3005: Integration of veliparib (V) with front-line chemotherapy and maintenance in women with high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin (HGSC)
    Coleman, R. L.
    Fleming, G. F.
    Brady, M. F.
    Swisher, E.
    Steffensen, K. D.
    Friedlander, M.
    Okamoto, A.
    Moore, K.
    Ben-Baruch, N.
    Werner, T. L.
    Oaknin, A.
    Nam, J-H.
    Leath, C. A., III
    Nicum, S.
    Cella, D.
    Sullivan, D. M.
    Ansell, P. J.
    Dinh, M.
    Aghajanian, C.
    Bookman, M. A.
    ANNALS OF ONCOLOGY, 2019, 30 : 895 - 896
  • [43] HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies
    Yeo, Min-Kyung
    Kim, Sup
    Yoo, Heon Jong
    Suh, Kwang-Sun
    Kim, Kyung-Hee
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [44] A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
    van der Biessen, Diane A. J.
    Gietema, Jourik A.
    de Jonge, Maja J. A.
    Desar, Ingrid M. E.
    den Hollander, Martha W.
    Dudley, Matthew
    Dunbar, Martin
    Hetman, Robert
    Serpenti, Camille
    Xiong, Hao
    Mittapalli, Rajendar K.
    Timms, Kirsten M.
    Ansell, Peter
    Ratajczak, Christine K.
    Shepherd, Stacie Peacock
    van Herpen, Carla M. L.
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 828 - 835
  • [45] A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
    Diane A. J. van der Biessen
    Jourik A. Gietema
    Maja J. A. de Jonge
    Ingrid M. E. Desar
    Martha W. den Hollander
    Matthew Dudley
    Martin Dunbar
    Robert Hetman
    Camille Serpenti
    Hao Xiong
    Rajendar K. Mittapalli
    Kirsten M. Timms
    Peter Ansell
    Christine K. Ratajczak
    Stacie Peacock Shepherd
    Carla M. L. van Herpen
    Investigational New Drugs, 2018, 36 : 828 - 835
  • [46] Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects
    Chu, Tang-Yuan
    Khine, Aye Aye
    Wu, Na-Yi Yuan
    Chen, Pao-Chu
    Chu, Sung-Chao
    Lee, Ming-Hsun
    Huang, Hsuan-Shun
    MOLECULAR CARCINOGENESIS, 2023, 62 (09) : 1417 - 1427
  • [47] Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (USP17) Gene Family, is a Potential Target for Epithelial-Mesenchymal Transition in High-Grade Serous Ovarian Cancer
    Yildirim, Nuri
    Kocal, Gizem Calibasi
    Isik, Zerrin
    Saatli, Bahadir
    Saygili, Ugur
    Uysal, Tugba
    Ulukus, Cagnur
    Koyuncuoglu, Meral
    Ellidokuz, Hulya
    Basbinar, Yasemin
    REPRODUCTIVE SCIENCES, 2019, 26 (06) : 794 - 805
  • [48] Part I of GANNET53: A multicenter phase I/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
    Ray-Coquard, Isabelle
    Braicu, Ioana
    Berger, Regina
    Mahner, Sven
    Sehouli, Jalid
    Zeimet, Alain G.
    lauraine, Eric Pujade
    Cassier, Philippe Alexandre
    Moll, Utemartha
    Ulmer, Hanno
    Leunen, Karin
    Marth, Christian
    Vergote, Ignace
    Concin, Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] Case 11-2006: A 54-year-old woman with a mass in the pelvis - Mixed high-grade serous papillary and transitional-cell carcinoma of the fallopian tube, FIGO stage IIIC.
    Krasner, CN
    Roche, M
    Horowitz, NS
    Supko, JG
    Lee, SI
    Oliva, E
    Harris, NL
    Fuller, AF
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15): : 1615 - 1625
  • [50] A multicenter phase II study of the efficacy and safety of quisinostat (an HDAC inhibitor) in combination with paclitaxel and carboplatin chemotherapy (CT) in patients (pts) with recurrent platinum resistant high grade serous epithelial ovarian, primarily peritoneal or fallopian tube carcinoma cancer (OC).
    Tjulandin, Sergei
    Fedyanin, Mikhail
    Vladimirov, Vladimir Ivanovich
    Kostorov, Vladimir
    Lisyanskaya, Alla Sergeevua
    Krikunova, Ludmila
    Cakana, Andrew
    Azarova, Valeria
    Karavaeva, Oksana
    Vostokova, Natalia
    Baranovsky, Sergey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35